Information:
Error:
ID
4282
Description
The purpose of this Phase II study is to determine if AZD4877, an experimental drug that is a novel anti-mitotic agent (Eg5 or Kinesin Spindle Protein inhibitor that interferes with tumor cell division leading to tumor growth), can reduce tumor sizes in patients with bladder cancer
Keywords
Versions (1)
- 12/6/13 12/6/13 - Martin Dugas
Uploaded on
December 6, 2013
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility DRKS00004052 NCT00661609 Advanced Bladder Cancer
Similar models
Eligibility
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Confirmed urothelial cancer
Item
boolean
CL363966 (NCI Metathesaurus CUI)
Disease stage
Item
boolean
C0474940 (NCI Metathesaurus CUI)
Chemotherapie
Item
boolean
C1518470 (NCI Metathesaurus CUI)
Selfcare
Item
boolean
C0036592 (NCI Metathesaurus CUI)
Prior treatment
Item
boolean
C1522449 (NCI Metathesaurus CUI)
C0949266 (NCI Metathesaurus CUI)
C0949266 (NCI Metathesaurus CUI)
Bone marrow
Item
boolean
C0005953 (NCI Metathesaurus CUI)
Liver function
Item
boolean
C0232744 (NCI Metathesaurus CUI)
Renal function
Item
boolean
C0341697 (NCI Metathesaurus CUI)